
zzso vaccines administered to patients with cancer are expected to induce and sustain zzso immune zzso However, zzso responses are often compromised in such patients, and a new approach to evaluating their immune competence before vaccination is zzso zzso zzso of activated zzso zzso cells, including zzso zzso T cells, occurring with a high frequency in the circulation of such patients may be one reason for low zzso of zzso T cells zzso after zzso For patients treated with zzso vaccines, monitoring strategies, including a broad range of zzso and cellular zzso have been zzso zzso zzso using circulating zzso and capable of detecting fewer than zzso of zzso T zzso in the tested population are currently in zzso zzso zzso zzso flow zzso zzso and zzso binding were recently compared by us as part of a zzso zzso zzso vaccination trial in patients with zzso zzso All three zzso performed under zzso conditions in an experienced monitoring laboratory detected a low frequency of zzso zzso T cells and were not found to be zzso in measuring zzso to zzso changes in the frequency of these T zzso The selection of an zzso for monitoring of zzso vaccines is an important decision, which has to be undertaken rationally with a complete understanding of the zzso zzso The zzso performance has to be validated in terms of sensitivity, zzso zzso and zzso zzso and its zzso of variation zzso Performance of an zzso with fresh zzso zzso specimens has to be evaluated zzso The challenge of serial monitoring in patients receiving therapeutic vaccines is best met by using experienced reference zzso 

